收费全文 | 11066篇 |
免费 | 805篇 |
国内免费 | 403篇 |
耳鼻咽喉 | 27篇 |
儿科学 | 160篇 |
妇产科学 | 82篇 |
基础医学 | 692篇 |
口腔科学 | 27篇 |
临床医学 | 1468篇 |
内科学 | 1732篇 |
皮肤病学 | 27篇 |
神经病学 | 1416篇 |
特种医学 | 420篇 |
外科学 | 1048篇 |
综合类 | 2414篇 |
预防医学 | 392篇 |
眼科学 | 84篇 |
药学 | 860篇 |
12篇 | |
中国医学 | 1367篇 |
肿瘤学 | 46篇 |
2024年 | 13篇 |
2023年 | 135篇 |
2022年 | 220篇 |
2021年 | 350篇 |
2020年 | 385篇 |
2019年 | 257篇 |
2018年 | 316篇 |
2017年 | 313篇 |
2016年 | 331篇 |
2015年 | 360篇 |
2014年 | 686篇 |
2013年 | 713篇 |
2012年 | 619篇 |
2011年 | 654篇 |
2010年 | 573篇 |
2009年 | 463篇 |
2008年 | 557篇 |
2007年 | 559篇 |
2006年 | 525篇 |
2005年 | 480篇 |
2004年 | 378篇 |
2003年 | 392篇 |
2002年 | 329篇 |
2001年 | 295篇 |
2000年 | 281篇 |
1999年 | 233篇 |
1998年 | 158篇 |
1997年 | 193篇 |
1996年 | 141篇 |
1995年 | 170篇 |
1994年 | 152篇 |
1993年 | 91篇 |
1992年 | 119篇 |
1991年 | 98篇 |
1990年 | 83篇 |
1989年 | 70篇 |
1988年 | 72篇 |
1987年 | 59篇 |
1986年 | 48篇 |
1985年 | 64篇 |
1984年 | 50篇 |
1983年 | 30篇 |
1982年 | 44篇 |
1981年 | 44篇 |
1980年 | 34篇 |
1979年 | 40篇 |
1978年 | 30篇 |
1977年 | 19篇 |
1976年 | 14篇 |
1974年 | 12篇 |
Areas covered: In this article, the effects of excipients and particle preparation methods on the properties of solid lipid nanocarriers (SLNCs) and their impact on drug absorption and efficacies related to different administration routes are reviewed and discussed.
Expert opinion: SLNCs have special characteristics, making them attractive as drug delivery systems, for parenteral and oral delivery for systemic effects, or ocular, pulmonary and topical delivery to enhance local treatment efficacy and reducing systemic side effects. Both excipients and fabrication methods are crucial for the function and size of nanoparticles and should be considered simultaneously in designing particles to obtain the optimal drug absorption and efficacy, especially for local treatments. Despite the demonstrated advantages by the preclinical studies, further studies on improved understanding of the interactions of SLNCs with biological tissues of the target site is necessary for efficient designing functional nanoparticles for clinical applications.
Abbreviations: DG: diglycerides; FFA: free fatty acids; GMS: glyceryl monostearate; MG: monoglycerides; NLC: nanostructured lipid carriers; PL: phospholipids; SLM: solid lipid microparticles; SLN: solid lipid nanoparticles; SLNC: solid lipid nanocarriers; TG: triglycerides. 相似文献
Aim: To explore performance of IADL seven years post-stroke onset and identify predictors of long-term IADL performance based on commonly employed acute measures and demographic characteristics in young and middle-aged stroke survivors.
Methods: Data on stroke survivors were collected from SAHLSIS. IADL performance was assessed at 7 years using the Frenchay Activities Index (FAI). Demographic data and baseline measures were assessed as predictors of FAI outcome, using logistic regression.
Results: 237 stroke survivors with a median age of 63 at follow-up were included. Participants had predominantly suffered a mild stroke and >90% lived at home with no community services. Mean FAI was 25.7(score range 0-45), indicating reduced levels of participation in IADL. Frequency of performance of IADL was lowest for work/leisure activities. Gender, cohabitation status, initial stroke severity and baseline score on mRS were independently associated with IADL outcome.
Conclusions: Reduced levels of participation in IADL persist many years after stroke onset and indicate a need to adapt a long-term perspective on stroke rehabilitation. 相似文献